Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
25,545,596
-
Share change
-
+930,721
-
Total reported value
-
$1,102,757,269
-
Put/Call ratio
-
308%
-
Price per share
-
$43.15
-
Number of holders
-
167
-
Value change
-
+$39,844,000
-
Number of buys
-
78
-
Number of sells
-
75
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2014
As of 30 Jun 2014,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,545,596 shares.
The largest 10 holders included
Fisher Asset Management, LLC, COMMONWEALTH BANK OF AUSTRALIA, FIL Ltd, BlackRock Group LTD, VANGUARD GROUP INC, SCHRODER INVESTMENT MANAGEMENT GROUP, HANSBERGER GLOBAL INVESTORS INC/FL, JPMORGAN CHASE & CO, AQR CAPITAL MANAGEMENT LLC, and Sectoral Asset Management Inc.
This page lists
167
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.